


Healthcare News Roundup: Biopharmaceutical
HSMN NewsFeed - 1 Sep 2017
ANI Pharmaceuticals Announces Approval and Launch of Oxycodone Hydrochloride Oral Solution, 100 mg/5mL
ANI Pharmaceuticals Announces Approval and Launch of Oxycodone Hydrochloride Oral Solution, 100 mg/5mL
HSMN NewsFeed - 31 Aug 2017
U.S. FDA Approves Chemo Group's Benznidazole to Treat Children with Chagas Disease
U.S. FDA Approves Chemo Group's Benznidazole to Treat Children with Chagas Disease
HSMN NewsFeed - 31 Aug 2017
RegeneRx Completes License Expansion for RGN-137 in Europe, S. Korea, Japan, Canada and Australia
RegeneRx Completes License Expansion for RGN-137 in Europe, S. Korea, Japan, Canada and Australia
HSMN NewsFeed - 30 Aug 2017
PhRMA Announces Dr. Richard Moscicki as New Chief Medical Officer and Executive Vice President
PhRMA Announces Dr. Richard Moscicki as New Chief Medical Officer and Executive Vice President
HSMN NewsFeed - 29 Aug 2017
Sorrento Therapeutics, Inc. Submits NDA For ZTlido(TM) Next-Generation Lidocaine Patch
Sorrento Therapeutics, Inc. Submits NDA For ZTlido(TM) Next-Generation Lidocaine Patch
HSMN NewsFeed - 28 Aug 2017
CSL Behring to Acquire Biotech Company Calimmune and its Proprietary Stem Cell Gene Therapy Platform
CSL Behring to Acquire Biotech Company Calimmune and its Proprietary Stem Cell Gene Therapy Platform
HSMN NewsFeed - 23 Aug 2017
Stryker provides an update regarding Sage warning letter and revised financial guidance
Stryker provides an update regarding Sage warning letter and revised financial guidance
HSMN NewsFeed - 23 Aug 2017
Macrophage Pharma Limited Extends Series A Round to Include New Investor Merck Ventures
Macrophage Pharma Limited Extends Series A Round to Include New Investor Merck Ventures
HSMN NewsFeed - 17 Aug 2017
Mylan Finalizes Settlement Agreement on Medicaid Rebate Classification for EpiPen(R) Auto-Injector
Mylan Finalizes Settlement Agreement on Medicaid Rebate Classification for EpiPen(R) Auto-Injector
HSMN NewsFeed - 16 Aug 2017
Perrigo Announces FDA Final Approval for its AB Rated Generic Version of Mycolog(R) II Cream
Perrigo Announces FDA Final Approval for its AB Rated Generic Version of Mycolog(R) II Cream
HSMN NewsFeed - 15 Aug 2017
Pharmalink Strengthens Its Management Team. Appoints New Chief Financial Officer and Head of Communications
Pharmalink Strengthens Its Management Team. Appoints New Chief Financial Officer and Head of Communications
HSMN NewsFeed - 14 Aug 2017
Regeneron to Discontinue Development of Suptavumab for Respiratory Syncytial Virus
Regeneron to Discontinue Development of Suptavumab for Respiratory Syncytial Virus
HSMN NewsFeed - 14 Aug 2017
Synthorx Appoints Marcos Milla, Ph.D. as Senior Vice President of Research
Synthorx Appoints Marcos Milla, Ph.D. as Senior Vice President of Research
HSMN NewsFeed - 14 Aug 2017
Merrimack Augments Executive Team with Appointment of Jean Franchi as Chief Financial Officer
Merrimack Augments Executive Team with Appointment of Jean Franchi as Chief Financial Officer
HSMN NewsFeed - 10 Aug 2017
Aevi Genomic Medicine Announces Agreement for $28 Million Private Placement
Aevi Genomic Medicine Announces Agreement for $28 Million Private Placement
HSMN NewsFeed - 24 Jul 2017
CTI BioPharma Appoints Biotechnology Industry Veteran Laurent Fischer, M.D., to Board of Directors
CTI BioPharma Appoints Biotechnology Industry Veteran Laurent Fischer, M.D., to Board of Directors
HSMN NewsFeed - 21 Jul 2017
CSL Behring Receives Orphan-Drug Exclusivity for HAEGARDA(R) (C1 Esterase Inhibitor Subcutaneous [Human])
CSL Behring Receives Orphan-Drug Exclusivity for HAEGARDA(R) (C1 Esterase Inhibitor Subcutaneous [Human])
HSMN NewsFeed - 21 Jul 2017
Teligent, Inc. Announces FDA Approval Of Erythromycin Topical Gel USP, 2%
Teligent, Inc. Announces FDA Approval Of Erythromycin Topical Gel USP, 2%
HSMN NewsFeed - 21 Jul 2017
EMA's CHMP Issues Positive Opinion for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma
EMA's CHMP Issues Positive Opinion for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma
HSMN NewsFeed - 21 Jul 2017
Lexicon Collaborator Ipsen Receives Positive CHMP Opinion For Xermelo(R) (Telotristat Ethyl)
Lexicon Collaborator Ipsen Receives Positive CHMP Opinion For Xermelo(R) (Telotristat Ethyl)
HSMN NewsFeed - 20 Jul 2017
Churchill Pharmaceuticals Announces NDA Filing Acceptance for YONSA(TM) by the U.S. FDA
Churchill Pharmaceuticals Announces NDA Filing Acceptance for YONSA(TM) by the U.S. FDA
HSMN NewsFeed - 19 Jul 2017
Dr. Moncef Slaoui, former GlaxoSmithKline Chairman of Vaccines, Appointed to SutroVax Board of Directors
Dr. Moncef Slaoui, former GlaxoSmithKline Chairman of Vaccines, Appointed to SutroVax Board of Directors
HSMN NewsFeed - 19 Jul 2017
AcelRx Pharmaceuticals Appoints Raffi Asadorian as Chief Financial Officer
AcelRx Pharmaceuticals Appoints Raffi Asadorian as Chief Financial Officer
HSMN NewsFeed - 18 Jul 2017
Fagron, Inc. Announces Launch Of LETS GEL KIT(TM) for Rapid Topical Anesthesia
Fagron, Inc. Announces Launch Of LETS GEL KIT(TM) for Rapid Topical Anesthesia
HSMN NewsFeed - 17 Jul 2017
Phoenix Molecular Designs Appoints Leading Oncology Expert Dr. Gerrit Los as Chief Scientific Officer
Phoenix Molecular Designs Appoints Leading Oncology Expert Dr. Gerrit Los as Chief Scientific Officer
HSMN NewsFeed - 17 Jul 2017
Amgen And UCB Provide Update On Regulatory Status Of EVENITY(TM) (romosozumab) In The US
Amgen And UCB Provide Update On Regulatory Status Of EVENITY(TM) (romosozumab) In The US
HSMN NewsFeed - 14 Jul 2017
Lannett Receives Approval For Cyproheptadine Hydrochloride Syrup, 2 mg/5 mL
Lannett Receives Approval For Cyproheptadine Hydrochloride Syrup, 2 mg/5 mL
HSMN NewsFeed - 12 Jul 2017
E-Scape Bio Series A Extension Brings Total Round to $63 Million to Fund Neurodegenerative Disease Pipeline
E-Scape Bio Series A Extension Brings Total Round to $63 Million to Fund Neurodegenerative Disease Pipeline
HSMN NewsFeed - 12 Jul 2017
Viking Therapeutics Completes Enrollment in Phase 2 Study of VK5211 in Patients Recovering from Hip Fracture
Viking Therapeutics Completes Enrollment in Phase 2 Study of VK5211 in Patients Recovering from Hip Fracture
